USA - NASDAQ:MASS - US65443P1021 - Common Stock
The current stock price of MASS is 7.38 USD. In the past month the price decreased by -7.75%. In the past year, price increased by 106.72%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| KEYS | KEYSIGHT TECHNOLOGIES IN | 26.25 | 31.08B | ||
| TDY | TELEDYNE TECHNOLOGIES INC | 24.16 | 24.06B | ||
| TRMB | TRIMBLE INC | 26.13 | 18.78B | ||
| ZBRA | ZEBRA TECHNOLOGIES CORP-CL A | 16.73 | 13.20B | ||
| AEIS | ADVANCED ENERGY INDUSTRIES | 37.56 | 8.18B | ||
| MIR | MIRION TECHNOLOGIES INC | 54.9 | 6.87B | ||
| CGNX | COGNEX CORP | 41.78 | 6.59B | ||
| VNT | VONTIER CORP | 12.09 | 5.57B | ||
| BMI | BADGER METER INC | 39.97 | 5.54B | ||
| RAL | RALLIANT CORP | 14.86 | 5.26B | ||
| ITRI | ITRON INC | 17.46 | 4.81B | ||
| OSIS | OSI SYSTEMS INC | 29.92 | 4.79B |
908 Devices, Inc. engages in the development of measurement devices for chemical and biochemical analysis. The company is headquartered in Burlington, Massachusetts and currently employs 246 full-time employees. The company went IPO on 2020-12-18. Its devices are used at the point-of-need to interrogate unknown and invisible materials and provide actionable answers to directly address some of the critical problems in forensics, bioprocessing, pharma/biopharma, life science research and adjacent markets. Its forensics & field detection products include MX908, XplorIR, ProtectIR, ThreatID, and InterceptIR. MX908 is a handheld, battery-powered, Mass Spec device designed for the analysis of solid, liquid, vapor and aerosol materials of unknown identity. MX908 is a multi-purpose device utilized by a spectrum of user segments for a variety of forensic field applications, including chemical, explosive, priority drug and hazardous materials operations, detecting materials at the trace level. XplorIR is a handheld gas detector that can detect and quantify unknown chemicals and vapors in seconds.
908 DEVICES INC
44 Third Avenue
Burlington MASSACHUSETTS 02210 US
CEO: Kevin J. Knopp
Employees: 246
Phone: 19787294478
908 Devices, Inc. engages in the development of measurement devices for chemical and biochemical analysis. The company is headquartered in Burlington, Massachusetts and currently employs 246 full-time employees. The company went IPO on 2020-12-18. Its devices are used at the point-of-need to interrogate unknown and invisible materials and provide actionable answers to directly address some of the critical problems in forensics, bioprocessing, pharma/biopharma, life science research and adjacent markets. Its forensics & field detection products include MX908, XplorIR, ProtectIR, ThreatID, and InterceptIR. MX908 is a handheld, battery-powered, Mass Spec device designed for the analysis of solid, liquid, vapor and aerosol materials of unknown identity. MX908 is a multi-purpose device utilized by a spectrum of user segments for a variety of forensic field applications, including chemical, explosive, priority drug and hazardous materials operations, detecting materials at the trace level. XplorIR is a handheld gas detector that can detect and quantify unknown chemicals and vapors in seconds.
The current stock price of MASS is 7.38 USD. The price decreased by -5.38% in the last trading session.
MASS does not pay a dividend.
MASS has a ChartMill Technical rating of 7 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
908 DEVICES INC (MASS) operates in the Information Technology sector and the Electronic Equipment, Instruments & Components industry.
You can find the ownership structure of 908 DEVICES INC (MASS) on the Ownership tab.
The outstanding short interest for 908 DEVICES INC (MASS) is 5.85% of its float.
ChartMill assigns a technical rating of 7 / 10 to MASS. When comparing the yearly performance of all stocks, MASS is one of the better performing stocks in the market, outperforming 94.43% of all stocks.
ChartMill assigns a fundamental rating of 4 / 10 to MASS. No worries on liquidiy or solvency for MASS as it has an excellent financial health rating, but there are worries on the profitability.
Over the last trailing twelve months MASS reported a non-GAAP Earnings per Share(EPS) of -0.98. The EPS increased by 10.09% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -9.62% | ||
| ROE | -12.39% | ||
| Debt/Equity | 0 |
10 analysts have analysed MASS and the average price target is 10.2 USD. This implies a price increase of 38.21% is expected in the next year compared to the current price of 7.38.
For the next year, analysts expect an EPS growth of 26.58% and a revenue growth -3.72% for MASS